Display options
Cite
Sharmila Banu G, Kumar G, Murugesan AG. Ethanolic leaves extract of Trianthema portulacastrum L. ameliorates aflatoxin B(1) induced hepatic damage in rats. Indian J Clin Biochem. 2009;24(3):250-6doi: 10.1007/s12291-009-0047-5.
Sharmila Banu, G., Kumar, G., & Murugesan, A. G. (2009). Ethanolic leaves extract of Trianthema portulacastrum L. ameliorates aflatoxin B(1) induced hepatic damage in rats. Indian journal of clinical biochemistry : IJCB, 24(3), 250-6. https://doi.org/10.1007/s12291-009-0047-5
Sharmila Banu, G, et al. "Ethanolic leaves extract of Trianthema portulacastrum L. ameliorates aflatoxin B(1) induced hepatic damage in rats." Indian journal of clinical biochemistry : IJCB vol. 24,3 (2009): 250-6. doi: https://doi.org/10.1007/s12291-009-0047-5
Sharmila Banu G, Kumar G, Murugesan AG. Ethanolic leaves extract of Trianthema portulacastrum L. ameliorates aflatoxin B(1) induced hepatic damage in rats. Indian J Clin Biochem. 2009 Jul;24(3):250-6. doi: 10.1007/s12291-009-0047-5. Epub 2009 Sep 16. PMID: 23105844; PMCID: PMC3453304.
Copy Download .nbib Format: NLM
Share it on

Indian J Clin Biochem. 2009 Jul;24(3):250-6. doi: 10.1007/s12291-009-0047-5. Epub 2009 Sep 16.

Ethanolic leaves extract of Trianthema portulacastrum L. ameliorates aflatoxin B(1) induced hepatic damage in rats.

Indian journal of clinical biochemistry : IJCB

G Sharmila Banu, Ganeshan Kumar, A G Murugesan

Affiliations

  1. Centre for Biotechnology, Muthayammal College of Arts and Sciences, Kakkaveri, Rasipuram, Namakkal, Tamilnadu, 637408 India.

PMID: 23105844 PMCID: PMC3453304 DOI: 10.1007/s12291-009-0047-5

Abstract

Aflatoxins are potent hepatotoxic and hepatocarcinogenic agents. Reactive oxygen species and consequent peroxidative damage caused by aflatoxin are considered to be the main mechanisms leading to hepatotoxicity. The present investigation aims at assessing the hepatoprotective effect of ethanolic leaves extract of Trianthema portulacastrum on aflatoxin B(1) (AFB(1))-induced hepatotoxicity in a rat model. The hepatoprotection of T. portulacastrum is compared with silymarin, a well known standard hepatoprotectant. Lactate dehydrogenase, alkaline phosphatase, alanine and aspartate aminotransferases were found to be significantly increased in the serum and decreased in the liver of AFB(1) administered (1 mg/kg bw, orally) rats, suggesting hepatic damage. Marked increase in the lipid peroxide levels and a concomitant decrease in the enzymic (superoxide dismutase, catalase, glutathione peroxidase, glutathione reductase, glucose-6-phosphate dehydrogenase and glutathione-S-transferase) and nonenzymic (reduced glutathione, vitamin C and vitamin E) antioxidants in the hepatic tissue were observed in AFB1 administered rats. Pretreatment with T. portulacastrum (100 mg/kg/p.o) and silymarin (100 mg/kg /p.o) for 7 days reverted the condition to near normal. The results of this study indicate that the ethanolic leaves extract of T. portulacastrum is a potent hepatoprotectant as silymarin.

Keywords: Aflatoxin B1; Hepatocarcinogenic; Hepatotoxic; Trianthema portulacastrum

References

  1. Chem Res Toxicol. 1992 Jul-Aug;5(4):470-8 - PubMed
  2. Clin Cancer Res. 2004 Aug 1;10(15):4901-12 - PubMed
  3. Carcinogenesis. 1994 May;15(5):947-55 - PubMed
  4. Cancer Res. 1975 Oct;35(10):2845-52 - PubMed
  5. Cell Tissue Res. 2004 Oct;318(1):201-13 - PubMed
  6. Clin Microbiol Rev. 2003 Jul;16(3):497-516 - PubMed
  7. Planta Med. 1989 Oct;55(5):420-2 - PubMed
  8. Vet Q. 1999 Oct;21(4):115-20 - PubMed
  9. Annu Rev Nutr. 2005;25:151-74 - PubMed
  10. Comp Biochem Physiol C Toxicol Pharmacol. 2003 Nov;136(3):205-12 - PubMed
  11. Eur J Biochem. 1974 Sep 16;47(3):469-74 - PubMed
  12. Biochem Biophys Res Commun. 1974 Feb 4;56(3):836-42 - PubMed
  13. Hepatology. 1999 Aug;30(2):573-5 - PubMed
  14. Phytother Res. 2001 Jun;15(4):307-10 - PubMed
  15. Biochim Biophys Acta. 1969 Jul 8;185(1):39-48 - PubMed
  16. Comp Biochem Physiol C Toxicol Pharmacol. 2002 Jun;132(2):193-201 - PubMed
  17. Cancer Lett. 1998 Jul 3;129(1):7-13 - PubMed
  18. Toxicol Appl Pharmacol. 1994 Jul;127(1):145-50 - PubMed
  19. Biochem Biophys Res Commun. 2005 Dec 9;338(1):668-76 - PubMed
  20. Hum Exp Toxicol. 2005 Jun;24(6):313-8 - PubMed
  21. Life Sci. 2001 Jun 8;69(3):309-26 - PubMed
  22. Methods Enzymol. 1979;62:3-11 - PubMed
  23. Br J Cancer. 1980 Aug;42(2):319-25 - PubMed
  24. Methods Enzymol. 1984;105:138-47 - PubMed
  25. Comp Biochem Physiol C Toxicol Pharmacol. 2001 Jan;128(1):19-26 - PubMed
  26. Crit Rev Food Sci Nutr. 2003;43(3):245-64 - PubMed
  27. Bioorg Med Chem. 2004 Nov 1;12(21):5677-87 - PubMed
  28. Science. 1973 Feb 9;179(4073):588-90 - PubMed
  29. Carcinogenesis. 1991 Mar;12(3):459-62 - PubMed
  30. Proc Assoc Am Physicians. 1999 Jan-Feb;111(1):10-5 - PubMed
  31. J Appl Toxicol. 2000 Sep-Oct;20(5):413-7 - PubMed
  32. Free Radic Biol Med. 2003 Nov 15;35(10):1330-40 - PubMed
  33. Phytomedicine. 2003 Mar;10(2-3):165-9 - PubMed
  34. Lab Invest. 1993 Sep;69(3):261-74 - PubMed
  35. J Biol Chem. 1974 Nov 25;249(22):7130-9 - PubMed
  36. Asian J Androl. 2001 Sep;3(3):217-21 - PubMed
  37. J Biol Chem. 1951 Nov;193(1):265-75 - PubMed
  38. Biochim Biophys Acta. 1979 Jan 4;582(1):67-78 - PubMed
  39. Crit Rev Toxicol. 2005 Oct-Nov;35(8-9):673-83 - PubMed
  40. Anal Biochem. 1972 Jun;47(2):389-94 - PubMed
  41. J Ethnopharmacol. 2004 May;92(1):37-40 - PubMed
  42. Mol Aspects Med. 2005 Aug-Oct;26(4-5):340-52 - PubMed

Publication Types